Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil plus remimazolam for sedation quality in painless gastrointestinal endoscopy
ChiCTR2300067349Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesia Surgery, Gansu Provincial People's Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in gastrointestinal conditions comparing Ciprofol + alfentanil with Remimazolam + alfentanil (2 arms). Primary endpoints: Incidence of intraoperative adverse events and Anesthesia recovery time. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
remimazolamciprofolalfentanil
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2300067349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067349.